Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis

20260 citationsJournal Article

Authors

Klara R. Klein · University of North Carolina at Chapel Hill

Anna Menacher · Novo Nordisk (Denmark)

John B. Buse · University of North Carolina at Chapel Hill

Johannes F.E. Mann · Universitätsklinikum Erlangen

Katherine R. Tuttle · University of Washington

Kajsa Kvist · Novo Nordisk (Denmark)

Margit Riis Andersen

Abstract

Although more evidence is needed, continuation of semaglutide after dialysis initiation appears safe and warrants efficacy testing regarding reduction in MACE and death.

Topics & Keywords

Diabetes Treatment and Management Cardiovascular Function and Risk Factors Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

DOI: 10.2337/dc26-0112

Field-Weighted Citation Impact: 0.00